Introduction Cervical cancer is the leading cause of cancer deaths in women in the
developing world. New technologies have been developed to allow for more rapid, cost …

This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

Human papillomaviruses (HPV) are the first viruses to have been acknowledged to prompt
carcinogenesis, and they are linked with cancers of the uterine cervix, anogenital tumors …

Cervical cancer affects nearly 4% of the women across the globe and leads to mortality if not
treated in early stage. A few decades before, the mortality rate was too high when compared …

Screening in women has decreased the incidence and mortality of cervical cancer.
Precancerous cervical lesions (cervical intraepithelial neoplasias) and cervical carcinomas …

Aim Human papillomavirus (HPV) is the etiologic agent of the majority of cervical
intraepithelial lesions (CIN) and cervical cancers. While prophylactic HPV vaccines prevent …

Cervical cancer is a common malignant tumour of the female reproductive system that
seriously threatens the health of women. The aims of this study were to identify key genes …

MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in cervical
carcinogenesis and progression. microRNA-133a (miR-133a) has been reported to play a …

Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth
leading cause of cancer death in women. Major advances but still insufficient achievements …

Cervical cancer is the second most common women carcinoma worldwide and the fourth
leading cause of cancer‑associated mortality in women. Butein, a bioactive flavonoid …